| Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort studyCommentary: Why do doctors overestimate? Commentary: Prognoses should … NA Christakis, JL Smith, CM Parkes, EB Lamont Bmj 320 (7233), 469-473, 2000 | 1931 | 2000 |
| Cost of care for elderly cancer patients in the United States KR Yabroff, EB Lamont, A Mariotto, JL Warren, M Topor, A Meekins, ... Journal of the National Cancer Institute 100 (9), 630-641, 2008 | 805 | 2008 |
| Prognostic disclosure to patients with cancer near the end of life EB Lamont, NA Christakis Annals of internal medicine 134 (12), 1096-1105, 2001 | 663 | 2001 |
| Evaluation of trends in the cost of initial cancer treatment JL Warren, KR Yabroff, A Meekins, M Topor, EB Lamont, ML Brown Journal of the National Cancer Institute 100 (12), 888-897, 2008 | 455 | 2008 |
| Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study SJ Hotte, EW Winquist, E Lamont, M MacKenzie, E Vokes, EX Chen, ... Journal of Clinical Oncology 23 (3), 585-590, 2005 | 311 | 2005 |
| Complexities in prognostication in advanced cancer: to help them live their lives the way they want to EB Lamont, NA Christakis Jama 290 (1), 98-104, 2003 | 278 | 2003 |
| Rural residence and cancer outcomes in the United States: issues and challenges A Meilleur, SV Subramanian, JJ Plascak, JL Fisher, ED Paskett, ... Cancer epidemiology, biomarkers & prevention 22 (10), 1657-1667, 2013 | 256 | 2013 |
| Patient time costs associated with cancer care KR Yabroff, WW Davis, EB Lamont, A Fahey, M Topor, ML Brown, ... Journal of the National Cancer Institute 99 (1), 14-23, 2007 | 253 | 2007 |
| Tumor boards and the quality of cancer care NL Keating, MB Landrum, EB Lamont, SR Bozeman, LN Shulman, ... Journal of the National Cancer Institute 105 (2), 113-121, 2013 | 234 | 2013 |
| Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives LA Dow, RK Matsuyama, V Ramakrishnan, L Kuhn, EB Lamont, ... Journal of Clinical Oncology 28 (2), 299-304, 2010 | 234 | 2010 |
| Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer TJ Iwashyna, EB Lamont Journal of Clinical Oncology 20 (19), 3992-3998, 2002 | 210 | 2002 |
| Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia SK Gupta, EB Lamont Journal of the American Geriatrics Society 52 (10), 1681-1687, 2004 | 179 | 2004 |
| Is patient travel distance associated with survival on phase II clinical trials in oncology? EB Lamont, D Hayreh, KE Pickett, JJ Dignam, MA List, KM Stenson, ... Journal of the National Cancer Institute 95 (18), 1370-1375, 2003 | 162 | 2003 |
| Physician factors in the timing of cancer patient referral to hospice palliative care EB Lamont, NA Christakis Cancer 94 (10), 2733-2737, 2002 | 149 | 2002 |
| The oral fluoropyrimidines in cancer chemotherapy EB Lamont, RL Schilsky Clinical cancer research 5 (9), 2289-2296, 1999 | 143 | 1999 |
| Paradoxes in cancer patients' advance care planning EB Lamont, M Siegler Journal of palliative medicine 3 (1), 27-35, 2000 | 120 | 2000 |
| Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study NL Keating, MB Landrum, EB Lamont, SR Bozeman, SH Krasnow, ... Annals of internal medicine 154 (11), 727-736, 2011 | 99 | 2011 |
| Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344) EB Lamont, JE Herndon, JC Weeks, IC Henderson, CC Earle, RL Schilsky, ... Journal of the National Cancer Institute 98 (18), 1335-1338, 2006 | 97 | 2006 |
| A demographic and prognostic approach to defining the end of life EB Lamont Journal of palliative medicine 8 (supplement 1), s-12-s-21, 2005 | 95 | 2005 |
| Chemotherapy in the management of squamous-cell carcinoma of the head and neck EB Lamont, EE Vokes The Lancet Oncology 2 (5), 261-269, 2001 | 93 | 2001 |